FDA
-
-
-
-
-
-
-
Anixa gets approval to increase CAR-T doses up to 100x in cancer trial
-
-
-
-
-
-
-
Anixa Biosciences begins IND transfer for phase 2 breast cancer vaccine trial
-
-
-
-
-
-
-
Anixa Biosciences (ANIX) CEO Provides Letter to Shareholders
-
-
-
-
-
-
-
Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy
-
-
-
-
-
-
-
Anixa Biosciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
-
-
-
-
-
-
-
UPDATE: H.C. Wainwright Starts Anixa Biosciences (ANIX) at Buy
-
-
-
-
-
-
-
Anixa Biosciences to Present at the H.C. Wainwright BioConnect 2021 Conference
-
334,273 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


